Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pene Dumitrescu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics: Focus on the PatientT Pene Dumitrescu, M J Fossler, V D Schmith
Oncogene|September 17, 2008
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259T Pene-Dumitrescu, L F Peterson, N J Donato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2017
A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosisA Nasir, R Bissonnette, C Maari, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjectsT Pene Dumitrescu, T Anic-Milic, K Oreskovic, et al.
Clinical and Translational Science|June 16, 2016
A Novel Method for Studying the Pharmacokinetics of [(14) C]Umeclidinium After Application to the Axilla or Palm of Healthy Male SubjectsT Pene Dumitrescu, L L Santos, S C Hughes, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics: Focus on the PatientT Pene Dumitrescu, M J Fossler, V D Schmith
Oncogene|September 17, 2008
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259T Pene-Dumitrescu, L F Peterson, N J Donato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2017
A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosisA Nasir, R Bissonnette, C Maari, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjectsT Pene Dumitrescu, T Anic-Milic, K Oreskovic, et al.
Clinical and Translational Science|June 16, 2016
A Novel Method for Studying the Pharmacokinetics of [(14) C]Umeclidinium After Application to the Axilla or Palm of Healthy Male SubjectsT Pene Dumitrescu, L L Santos, S C Hughes, et al.
Pageof 1